Drug
Ziv Aflibercept
Ziv Aflibercept: highest development phase Approved, developed by Regeneron, Sanofi. 2 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- Regeneron, Sanofi
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZALTRAP | Approved | |
| ziv-aflibercept NCT00082823 | Phase 1 | Cancer |
Latest
No recent events.
Follow Ziv Aflibercept on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.